Caroline Wilson (@carwils) 's Twitter Profile
Caroline Wilson

@carwils

(she/her) @UCSF Tetrad phd candidate with @LukeGilbertSF | new yorker and genome engineer formerly @nyscf and @colbycollege

ID: 430286686

calendar_today07-12-2011 00:12:23

19 Tweet

123 Followers

495 Following

Xiaokun Shu (@shulab2010) 's Twitter Profile Photo

We have discovered a potent drug that blocks SARS-CoV-2 by a distinct mode of action: 1) EC50 ~ 80 nM by plaque assay; 2) it inactivates viral particles; 3) drug-treated coronavirus no longer binds to host cells. The drug is ethacridine. 1/n biorxiv.org/content/10.110…

Caroline Wilson (@carwils) 's Twitter Profile Photo

thinking about my transition to grad school and the first thing I thought about this morning was whether or not I’ll have my own premium snapgene subscription

Caroline Wilson (@carwils) 's Twitter Profile Photo

sci twitter q: what is the best way to manage scientific papers? What are the pros and cons of your pick? I'm a Papers user, but trying to decide if I should make a switch before beginning my phd!

Caroline Wilson (@carwils) 's Twitter Profile Photo

An incredibly sad loss of such an extraordinary woman and advocate. Susan transformed stem cell research and her legacy will continue with those touched by her vision for NYSCF.

Chris Hsiung 熊 (Recruiting Postdocs!) (@hsiung_chris) 's Twitter Profile Photo

Our preprint reporting a multiAsCas12a CRISPRi platform for >3plex combinatorial targeting of genes and/or enhancers (including 6plex in high-throughput pooled screens) is now a peer-reviewed publication! go.nature.com/3UTnSXM.

Ansu Satpathy (@satpathology) 's Twitter Profile Photo

Happy to share our new work describing DESynR genes! The evolution of new human protein-coding genes relies on repurposing protein domains from ancestral genes, rather than de novo sequence creation. New genes evolved from old parts, and while we have methods that enable

Happy to share our new work describing DESynR genes! 

The evolution of new human protein-coding genes relies  on repurposing protein domains from ancestral genes, rather than de novo sequence creation. New genes evolved from old parts, and while we have methods that enable